Renal transplantation - An experience of 500 patients

Medical Journal Armed Forces India

Volumn 63, Issue 2, 2007, Pages 107-111

  Varma, P P ^a   Hooda, A K ^a   Sinha, T ^a   Chopra, G S ^a   Karan, S C ^a   Sethi, G S ^a   Badwal, S ^a   Kotwal, A ^a  

^a ARMY HOSPITAL   (India)

Author keywords

Graft survival; Kidney transplant; Patient survival

Indexed keywords

ANTIBIOTIC AGENT; AZATHIOPRINE; CORTICOSTEROID DERIVATIVE; CYCLOSPORIN; INTERLEUKIN 2 RECEPTOR; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; THYMOCYTE ANTIBODY;

ACUTE GRAFT REJECTION; ADULT; AGED; ARTICLE; CADAVER DONOR; CONTROLLED STUDY; DEATH; DRUG DOSE REDUCTION; DRUG WITHDRAWAL; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; GROUPS BY AGE; HIGH RISK POPULATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; MAJOR CLINICAL STUDY; MALE; PUBLIC HOSPITAL; SEX RATIO; SURVIVAL RATE; URINARY TRACT INFECTION;

EID: 34548386695     PISSN: 03771237     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0377-1237(07)80049-9     Document Type: Article

References (31)

1. Scientific registry of transplant recipients, 2004 OPTN/SRTR Annual Report.
2. Hariharan S, Johnson CP, Bresnahan BA, et al. Improved graft survival after renal transplantation in United States; 1988-1996. NEJM 2000; 342: 605-12.
3. Stratta RJ, Alloway RR, Hodge E, Lo A. A multicentric, open label comparative trial of two doses of daclizumab dosing strategies vs no antibody induction in combination with tacrolimus, mycophenolate mofetil and steroids for the prevention of acute rejection in simultaneous kidney-pancreas transplant recipients. Clin Transplant 2002; 16: 60-8.
4. Webster AC, Woodroff RC, Taylor RS, Chapman JR, Craig JC. Tacrolimus versus cyclosporine as primary immunosuppressive for kidney transplant recipients: meta-analysis and meta-regression of randomized trial data. BMJ 2005; 331: 810-5.
5. Kasiske BL. Long term post transplantation complications and management. In: Danovitch GM, ed. Handbook of kidney transplantation. 3rd ed. Philadelphia: Williams and Wilkins, 2001; 183-4.
6. Canafox DM, Ascher NL. Cyclosporin immunosuppression. Clin Pharm 1983; 2: 515-24.
7. Mathew TH. A blinded long term randomized multicentric study of mycophenolate mofetil in cadaveric renal transplantation: results at 3 years. Tricontinent MMF renal transplant study group. Transplantation 1998; 65: 1450-4.
8. Placebo controlled study of mycophenolate mofetil combined with cyclosporine and steroids for prevention of acute rejection: European MMF study group. Lancet 1995; 345: 1321-5.
9. Mycophenolate for prevention of acute rejection in primary cadaveric allograft recipients: US renal transplantation MMF study group. Transplantation 1995; 60: 225-32.
10. Vincenti F, Jensik SC, Filo RS, Miller J, Pirsch J. A long-term comparison of Tacrolimus (FK506) an cyclosporine in kidney transplantation: Evidence for improved allograft survival at five years. Transplantation 2002; 23: 775-82.
11. Gonwa T, Johnson C, Ahsan N, et al. Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine after cadaveric kidney transplantation: results at three years. Transplantation 2003; 75: 2048-53.
12. Sonoda T, Takahara S, Takahashi K, et al. Outcome of 3 years of immummosuppression with tacrolimus in more than 1,000 renal transplant recipients in Japan. Transplantation 2003; 75: 199-204.
13. Andrews PA. Renal Transplantation - Recent developments. BMJ 2002; 324: 530-4.
14. Nashan B, Moore R, Amlot P, et al. Randomized trial of basiliximab versus placebo for control of acute cellular rejection in renal allograft recipients. CHIB International study group. Lancet 1997; 350: 1193-8.
15. Nashan B, Light S, Hardie IR, Lin A, Johnson JR. Reduction in acute renal allograft rejection by daclizumab. Daclizumab double therapy study group. Transplantation 1999; 67: 110-5.
16. Meier-Kriesche HU, Li S, Gruessner RWG, et al. Immunosuppression: Evolution in Practice and Trends, 1994-2004. Am J Transplant 2006; 6: 1111-31.
17. Goldfarb-Rumyantzev AS, Smith L, Shibab FS, et al. Role of maintenance immunosuppressive regimen in kidney transplant outcome. JASN 2006; 1: 563-74.
18. Srivastva AK, Sinha T, Varma PP, et al. Experience with marginal living related kidney donors: are they becoming routine or there are still any doubts? Urology 2005; 66: 971-5.
19. Alexender JW, Vaughan WK. Use of marginal donors for organ transplantation. The influence of donor age on outcome. Tansplantation 1991; 51: 135-41.
20. Lakshmi Kiran A, Saharian S. Spousal-renal transplantation. Ind J Nephrol 1999; 9: 53.
21. Hansen B, Rohr N, Svendsen V, et al. Bacterial urinary tract infection in cyclosporine-A immunosuppressed renal transplant recipients. Scand J Infect Dis 1988; 20: 425.
22. Gupta S, Kher V, Gulati S, et al. Urinary tract infection in renal allograft recipients. Ind J Nephrol 1996; 9: 207-10..
23. Kamath NS, John GT, Neelakantan N, Kirubakaran MG, Jacob CK. Bacterial infections after renal transplantation. Indian J Nephrol 2004; 14: 146.
24. Sakhuja V, Jha V, Varma PP, Joshi K, Chugh KS. The high incidence of tuberculosis among renal transplant recipients in India. Transplantation 1996; 61: 211-5.
25. John GT, Shankar V, Abraham AM, et al. Risk factors for post transplant tuberculosis. Kidney Int 2001; 60: 1148-51.
26. Pandays A, Wasfy S, Herbert D, Allen OD. Varicella zoster infection in paediatric solid organ transplant recipients: a hospital based study in pre-varicella vaccine era. Pediatr Transplant 2001; 5: 153-9.
27. Pereira BJ, Wright TL, Schmid CH, Levey S. New England Organ Study Group. The impact of pre-transplant hepatitis C infection on the outcome of renal transplantation. Transplantation 1995; 60: 779-85.
28. Narula AS, Hooda AK, Anand AC, Patrikar S. Impact of hepatitis C virus infection in renal transplant recipients. Ind J Gastroenterol 2005; 24: 151-4.
29. Agarwal SK, Dash SC, Irshad M, Gupta S, Bhowmik D, Tiwari SC. Impact of hepatitis C virus infection on renal transplant outcomes in India - A single centre study. J Assoc Physicians India 2000; 48: 1155-9.
30. Seth AK, Anand AC, Gedela SR, Varma PP, Baliga KV. Rapid progression of hepatitis C induced liver failure in renal allograft recipients. Ind J Gastroentrol 2006; 25: 155-6.
31. Srivastava A, Sinha T, Madhusoodanan P, et al. Urological complications of live related donor renal transplantation: 13 years experience at a single centre. Urology Int 2006; 77: 42-5.